Fitbit’s upcoming Sense smartwatch is its most advanced health tracker to date. And that claim only got stronger, as the company received FDA approval to activate the ECG cardiovascular program (ECG) before the watch was even released.
A smartwatch ECG monitors your heart rate and looks for evidence of atrial fibrillation (AFib), which is the most common type of irregular heartbeat. Due to the implications of health tracking, companies need FDA approval before they can offer the feature to users.
“Helping people understand and manage their heart health has always been a priority for Fitbit, and our new ECG app is designed for those users who want to assess themselves right now and review their reading later with their doctor,”; says Eric Friedman, Fitbit . co-founder and CTO. “Early detection of AFib is crucial, and I am extremely pleased that we are making these innovations available to people around the world to help them improve their heart health, prevent more serious conditions and potentially save lives.”
AFib can be difficult to detect and puts people at increased risk for stroke. Often people do not realize that they were in AFib until after a stroke. After all, early detection can lead to better health outcomes.
Fitbit Sense marks the third smartwatch with an app cleared for ECG use, after Apple Watch and Samsung. The termination will come just in time for Fitbit to release the new device with the feature turned on, something that Samsung did not succeed with the Galaxy Active2.